GLP-1 drugs, such as Ozempic and Wegovy, may slightly increase the risk of osteoporosis, gout, and the rare metabolic bone disease osteomalacia, a recent study suggests.
As these conditions are all … [+3996 chars]
No comments yet. Be the first to comment!